COMPANY

Taxis Pharmaceuticals Inc

HQ: Monmouth Junction, NJ source · taxispharma.com ↗ · Mid-Atlantic

Keywords: infectious disease antimicrobial resistance gonorrhea

Location: Monmouth Junction, NJ · source · Oct 15, 2026

Profile checked Oct 10, 2026

6NIH grants

Funding and NIH signals

NIH award NIH awarded $876K (SBIR Phase II 5R44AI174351-03, continuation, notice Sep 11, 2026); 3 NIH awards totaling $2.17M in the last 12 months. NIH RePORTER 5R44AI174351-03 (Sep 11, 2026)
Evidence (3 events)
- Sep 11, 2026 · NIH RePORTER 5R44AI174351-03
  Organization: TAXIS PHARMACEUTICALS, INC.; City/State: MONMOUTH JUNCTION, NJ; Project number: 5R44AI174351-03; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-09-11; FY total cost (award amount): 875798; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: Lead optimization of a novel cyclic aryl-indole efflux pump inhibitor (EPI) series in combination with levofloxacin against Pseudomonas aeruginosa; Organization type: Domestic For-Profits
- Aug 12, 2026 · NIH RePORTER 1R43AI197297-01
  Organization: TAXIS PHARMACEUTICALS, INC.; City/State: MONMOUTH JUNCTION, NJ; Project number: 1R43AI197297-01; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-08-12; FY total cost (award amount): 294729; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: Lead identification of oral FtsZ inhibitors for the treatment of Clostridioides difficile infections(CDI); Organization type: Domestic For-Profits
- May 26, 2026 · NIH RePORTER 5R44AI191886-02
  Organization: TAXIS PHARMACEUTICALS, INC.; City/State: MONMOUTH JUNCTION, NJ; Project number: 5R44AI191886-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-05-26; FY total cost (award amount): 1000000; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: Lead optimization of oral DHFR inhibitor for the treatment of multidrug-resistant N. gonorrhoeae infections.; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Timeline

Aug 19, 2026 Grant Government grant announced Aug 19, 2026. Source: company's own press page. source ↗

Funding

Last 2 years.

Aug 19, 2026 Government grant announced Aug 19, 2026. Source: company's own press page. source ↗

NIH awards 6

Annual award amounts. Total $5.0M.

Sep 11, 2026 NIH award 5R44AI174351-03 FY2026: $875,798 awarded for that fiscal year; activity R44 (SBIR); PI PARHI, AJIT K; recipient as written: TAXIS PHARMACEUTICALS, INC., MONMOUTH JUNCTION, NJ. Lead optimization of a novel c source ↗
Aug 12, 2026 NIH award 1R43AI197297-01 FY2026: $294,729 awarded for that fiscal year; activity R43 (SBIR); PI PARHI, AJIT K; recipient as written: TAXIS PHARMACEUTICALS, INC., MONMOUTH JUNCTION, NJ. Lead identification of oral Ft source ↗
May 26, 2026 NIH award 5R44AI191886-02 FY2026: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI PARHI, AJIT K; recipient as written: TAXIS PHARMACEUTICALS, INC., MONMOUTH JUNCTION, NJ. Lead optimization of oral DH source ↗
May 16, 2025 NIH award 1R44AI191886-01 FY2025: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI PARHI, AJIT K; recipient as written: TAXIS PHARMACEUTICALS, INC., MONMOUTH JUNCTION, NJ. Lead optimization of oral DH source ↗
Mar 25, 2025 NIH award 5R44AI174351-02 FY2025: $889,610 awarded for that fiscal year; activity R44 (SBIR); PI PARHI, AJIT K; recipient as written: TAXIS PHARMACEUTICALS, INC., MONMOUTH JUNCTION, NJ. Lead optimization of a novel c source ↗
Apr 26, 2024 NIH award 1R44AI174351-01A1 FY2024: $910,179 awarded for that fiscal year; activity R44 (SBIR); PI PARHI, AJIT K; recipient as written: TAXIS PHARMACEUTICALS, INC., MONMOUTH JUNCTION, NJ. Lead optimization of a novel source ↗